Diabetes, markers of brain pathology and cognitive function
- 16 November 2013
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 75 (1) , 138-146
Abstract
Objective: We investigated whether, and the extent to which, vascular and degenerative lesions in the brain mediate the association of diabetes with poor cognitive performance.Methods: This cross‐sectional study included 4,206 participants (age > 65 years; 57.8% women) of the Age, Gene/Environment Susceptibility–Reykjavik Study. Data were collected through interview, clinical examination, psychological testing, and laboratory tests. The composite scores on memory, information‐processing speed, and executive function were derived from a cognitive test battery. Markers of cerebral macrovascular (cortical infarcts), microvascular (subcortical infarcts, cerebral microbleeds, and higher white matter lesion volume), and neurodegenerative (lower gray matter, normal white matter, and total brain tissue volumes) processes were assessed on magnetic resonance images. Mediation models were employed to test the mediating effect of brain lesions on the association of diabetes with cognitive performance controlling for potential confounders.Results: There were 462 (11.0%) persons with diabetes. Diabetes was significantly associated with lower scores on processing speed and executive function, but not with memory function. Diabetes was significantly associated with all markers of brain pathology. All of these markers were significantly associated with lower scores on memory, processing speed, and executive function. Formal mediation tests suggested that markers of cerebrovascular and degenerative pathology significantly mediated the associations of diabetes with processing speed and executive function.Interpretation: Diabetes is associated with poor performance on cognitive tests of information‐processing speed and executive function. The association is largely mediated by markers of both neurodegeneration and cerebrovascular disease. Older people with diabetes should be monitored for cognitive problems and brain lesions. Ann Neurol 2014;75:138–146Keywords
This publication has 42 references indexed in Scilit:
- Brain Atrophy in Type 2 DiabetesDiabetes Care, 2013
- Neuropathologic basis of white matter hyperintensity accumulation with advanced ageNeurology, 2013
- Disruption of the Cerebral White Matter Network Is Related to Slowing of Information Processing Speed in Patients With Type 2 DiabetesDiabetes, 2013
- Neuropathologic Basis of Age-Associated Brain AtrophyJAMA Neurology, 2013
- Association of diabetes with amnestic and nonamnestic mild cognitive impairmentAlzheimer's & Dementia, 2013
- Glycemic Status and Brain Injury in Older IndividualsDiabetes Care, 2009
- Exploring effects of type 2 diabetes on cognitive functioning in older adults.Neuropsychology, 2009
- Insulin and neurodegenerative disease: shared and specific mechanismsThe Lancet Neurology, 2004
- Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRIDiabetologia, 2003
- Hippocampal volume as an index of Alzheimer neuropathologyNeurology, 2002